Cargando…
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
Autores principales: | Zhang, Jianying, Guo, Xiangqian, Jin, Bilian, Zhu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346231/ https://www.ncbi.nlm.nih.gov/pubmed/35936692 http://dx.doi.org/10.3389/fonc.2022.970623 |
Ejemplares similares
-
Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021) -
Editorial: The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory to Clinical Utility
por: Zhou, Jian-Guo, et al.
Publicado: (2021) -
Editorial: Bioinformatics Tools (and Web Server) for Cancer Biomarker Development
por: Xie, Longxiang, et al.
Publicado: (2020) -
Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer
por: Zhou, Juan, et al.
Publicado: (2021) -
Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)